Ultrasensitive Biomarker Analysis · Lifelog Data · AI Precision Medicine

Detect Earlier. Protect Longer.

Bredis Healthcare uses a single drop of blood to detect Alzheimer's at its earliest stages, and multimodal data to protect personalized cognitive health.

scroll

Where We Are Now

Ultrasensitive Immunoassay,
fg/mL Trace-Level
Biomarker Analysis

Built on cleanroom-based GCLP-certified infrastructure, we achieve world-class analytical accuracy. By detecting minute changes in blood proteins, we set new standards for clinical research and diagnostics.

View ChitaLabs
GCLP laboratory biomarker analysis
Multimodal lifelog health monitoring

Connected Future

Multimodal Data-Driven
Dementia Risk Analysis,
Redefining Prediction

Beyond one-time checks, we integrate 24-hour lifelog data from smart rings to proactively screen high-risk individuals and build personalized dementia risk prediction models.

Blood+Smart RingAI Report

Vision

Detect at the Earliest Stage,
Protect for the Longest Time

We detect subtle changes before symptoms appear and respond proactively. We predict disease risk in advance and provide personalized prevention strategies. Enabling longer, healthier lives — that is the vision of Bredis Healthcare.

Healthy aging and cognitive health
Ultrasensitive Blood Analysis+Lifelog Data IntegrationPersonalized Cognitive Health

Why Bredis Healthcare

01

GCLP-Certified Lab

Designated by Korea's MFDS as a clinical trial specimen analysis institution, delivering highly reliable biomarker results under strict quality control standards.

02

Ultrasensitive Biomarker Analysis

Built on advanced immunoassay platforms, we precisely measure even trace proteins undetectable by conventional ELISA.

03

Multimodal Data Integration

We integrate blood biomarkers, clinical and cognitive data, and wearable lifelogs to comprehensively analyze disease risk and health status.

04

Global Research Collaboration Network

We collaborate with universities, hospitals, and research institutes worldwide — including the National University of Singapore (NUS) — for joint research and clinical validation.

Bredis Healthcare in Numbers

2023

Founded

65,000+

Biomarker Analyses

80+

Clients & Partners

563+

Biomarkers

Key Certifications

GCLP Designated (MFDS)GMP CertifiedMFDS IVD RegistrationKC and CB CertificationDeep-Tech TIPS

Partners & Collaborators

ALAMAR BIOSCIENCES
NIH Korea
Hallym University Hospital
Hanyang University Hospital
Chungbuk National University
Ajou Unviersity
Kookmin University
KAIST
GARD cohort
Hanyang University Guri Hospital
Korea University Guro Hospital
Severance Hospital
Asan Medical Center
Seoul St Mary's Hospital
Seoul National University Hospital
National University of Singapore
Kyungpook National University Hospital
Pusan National University Hospital
Samsung Medical Center
Korea Hydro & Nuclear Power
OmniC&S
Yellosis
SD Biosensor
Deepson Bio
kolab Brain Healthcare
Boditech
D&P Biotech